RE:RE:CAR-T Abstract from Mayo Clinic (Vile group) using pela" Unfortunately, the efficacy of CAR T cell therapies against solid tumors is significantly limited, in large part due to impaired expansion/persistence in the immune suppressive tumor microenvironment (TME). "
[ONCY's pelareorep is capable of overcoming an immune suppressed TME to facilitate the addition of various I/O agents, as decribed in my earlier post ]
https://meetings.asco.org/abstracts-presentations/222671